Angiogenesis Inhibitors
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Chi-Square Distribution
Disease-Free Survival
Drug Synergism
Epirubicin
Female
Humans
Immunohistochemistry
Italy
Kaplan-Meier Estimate
Neoplasm Staging
Neovascularization, Pathologic
Proportional Hazards Models
Prospective Studies
Risk Assessment
Risk Factors
Tamoxifen
Time Factors
Tissue Array Analysis
Treatment Outcome
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor Receptor-2
